Literature DB >> 3597415

Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation.

R M Epand, A Gawish, M Iqbal, K B Gupta, C H Chen, J P Segrest, G M Anantharamaiah.   

Abstract

Four peptides capable of forming an amphipathic alpha-helix have been synthesized and their conformational and lipid-binding properties studied. These peptides have been designed to vary the alpha-helix-forming potential as well as the charge distribution of the model peptide. The resulting peptide analogs and their complexes with dimyristoyl phosphatidylcholine were studied by using right angle light scattering, negative stain electron microscopy, nondenaturing gradient gel electrophoresis, circular dichroism, intrinsic tryptophan fluorescence, and differential scanning calorimetry techniques. The four analogs, [Glu4,9, Leu11,17] (reverse-18A, [Glu4,9, Leu5,11,17] reverse-18A, [Glu1,8, Leu11,17] 18A, and [Glu1,8, Leu5,11,17] 18A were derived from a model amphipathic peptide Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Glu-Ala-Phe (18A) whose lipid-associating properties strongly mimic apolipoprotein A-I or derived from Lys-Trp-Leu-Asp-Ala-Phe-Tyr-Lys-Asp-Val-Ala-Lys-Glu-Leu-Glu-Lys-Ala-Phe (reverse-18A), a peptide with little affinity for lipid and having a reversed charge distribution compared to the 18A peptide. We have shown that by substituting glutamic acid and leucine for aspartic acid and alanine, respectively, in a weak lipid-associating amphipathic helix peptide, the lipid-associating ability can be increased. Thus, peptides with both kinds of charge distribution can associate with the lipid. The ability of the peptide to disrupt phospholipid bilayers, however, is higher for 18A analogs compared to the reverse-18A analogs even after increasing the helix-forming potential and hydrophobicity. In addition to forming smaller lipoprotein particles, the modified 18A analogs were much superior to the modified reverse-18A analogs in their ability to activate the enzyme lecithin:cholesterol acyltransferase. This demonstrates that the positions of charged residues in the amphipathic helix play an important role in lecithin:cholesterol acyltransferase activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597415

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Oligomeric self-association of basic fibroblast growth factor in the absence of heparin-like glycosaminoglycans.

Authors:  J C Davis; G Venkataraman; Z Shriver; P A Raj; R Sasisekharan
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

2.  Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus.

Authors:  W A Reed; P H Elzer; F M Enright; J M Jaynes; J D Morrey; K L White
Journal:  Transgenic Res       Date:  1997-09       Impact factor: 2.788

Review 3.  Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review.

Authors:  C Roger White; David W Garber; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2014-08-25       Impact factor: 5.922

Review 4.  HDL therapy for cardiovascular diseases: the road to HDL mimetics.

Authors:  C Roger White; Geeta Datta; Zhenghao Zhang; Himanshu Gupta; David W Garber; Vinod K Mishra; Mayakonda N Palgunachari; Shaila P Handattu; Manjula Chaddha; G M Anantharamaiah
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

5.  DNA-Corralled Nanodiscs for the Structural and Functional Characterization of Membrane Proteins and Viral Entry.

Authors:  Zhao Zhao; Meng Zhang; James M Hogle; William M Shih; Gerhard Wagner; Mahmoud L Nasr
Journal:  J Am Chem Soc       Date:  2018-08-16       Impact factor: 15.419

Review 6.  HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders.

Authors:  G S Getz; G D Wool; C A Reardon
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

7.  Folding of the β-Barrel Membrane Protein OmpA into Nanodiscs.

Authors:  DeeAnn K Asamoto; Guipeun Kang; Judy E Kim
Journal:  Biophys J       Date:  2019-11-28       Impact factor: 4.033

8.  Determination of the secondary structure of selected melittin analogues with different haemolytic activities.

Authors:  E Pérez-Payá; R A Houghten; S E Blondelle
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

9.  Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.).

Authors:  C Roger White; Geeta Datta; Paulina Mochon; Zhenghao Zhang; Ollie Kelly; Christine Curcio; Dale Parks; Mayakonda Palgunachari; Shaila Handattu; Himanshu Gupta; David W Garber; G M Anantharamaiah
Journal:  Vasc Dis Prev       Date:  2009-01-01

10.  Changes in helical content or net charge of apolipoprotein C-I alter its affinity for lipid/water interfaces.

Authors:  Nathan L Meyers; Libo Wang; Olga Gursky; Donald M Small
Journal:  J Lipid Res       Date:  2013-05-13       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.